Catalyst Pharmaceuticals (CPRX) Amortizatization of Intangibles (2022 - 2026)
Catalyst Pharmaceuticals posted quarterly Amortizatization of Intangibles of $9.7 million for Q1 2026, up 16071.67% year-on-year from N/an in Q1 2025, and down 73.96% on a QoQ basis from $37.3 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 5 years of Amortizatization of Intangibles data on file, last reported at $9.7 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 16071.67% year-over-year to $9.7 million; the trailing twelve-month figure through Mar 2026 stood at $48.3 million (down 7.96% YoY), and the FY2025 full-year result was $37.5 million, changed 0.32% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $9.7 million, down from $37.3 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $37.3 million in Q4 2025 and bottomed at -$535000.0 in Q4 2022.
- The 5-year median for Amortizatization of Intangibles is $4.4 million (2023), against an average of $8.3 million.
- The widest annual swing landed in 2024, when Amortizatization of Intangibles surged 21123.56%; it then sank 93.67% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$535000.0 in 2022, then soared by 67.48% to -$174000.0 in 2023, then soared by 21123.56% to $36.6 million in 2024, then grew by 1.87% to $37.3 million in 2025, then plunged by 73.96% to $9.7 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $9.7 million (Q1 2026), $37.3 million (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.70 Mn |
| Mar 31, 2026 | 9.70 Mn |
| Dec 31, 2025 | 37.26 Mn |
| Dec 31, 2025 | 37.26 Mn |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 36.58 Mn |
| Dec 31, 2024 | 36.58 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | -153,000.00 |
| Mar 31, 2024 | -153,000.00 |
| Dec 31, 2023 | -174,000.00 |
| Dec 31, 2023 | -174,000.00 |
| Sep 30, 2023 | 7.90 Mn |
| Sep 30, 2023 | 7.90 Mn |
| Jun 30, 2023 | 7.90 Mn |
| Jun 30, 2023 | 7.90 Mn |
| Dec 31, 2022 | -535,000.00 |
| Dec 31, 2022 | -535,000.00 |
| Sep 30, 2022 | 500,000.00 |
| Sep 30, 2022 | 500,000.00 |